Differentiation state affects PD-L1 expression in cutaneous melanoma: a systematic review
{{output}}
Background: Programmed death ligand-1 (PD-L1) is a widely used biomarker for immunotherapy in melanoma. The expression of PD-L1 in melanoma cells is known to vary considerably among and within patients' tumor samples. Recent stu... ...
